Post-Merger R&D Integration demo
An acquired biotech's data room, lab notebooks and study reports turned into a cited, signed dossier for each asset, before the people who wrote them leave. 1:14
What the demo shows
An R&D integration solution for acquirers that turns a biotech's data room into asset dossiers.
Six agents read every inherited file in place, extract each fact with its page, find where drafts, summaries and notebooks disagree, and draft one cited dossier per asset. The home is a treemap of the inherited science, colored by how much is cited; workstreams written by people who are leaving are hatched with their departure date, so walkthroughs are booked before they go. Function owners resolve and sign.
Transcript
- Post-Merger R&D Integration turns an acquired biotech's data room into signed asset dossiers for the acquirer scientists.
- After a biotech deal, scientists' turnover rises 13% and their knowledge leaves too.
- Replay from the close.
- Programs turn green as the agents read the data room.
- Hatch tiles come from people who are leaving.
- These is saying notebooks have one author.
- She leaves in 19 days.
- Priya books her walkthrough with the questions only she can answer.
- In toxicology, the IND summary still uses the draft dog in OEL.
- 50, not 15. Dr.
- Maya Chun takes the final report, and the dossier is rewritten.
- She signs a cited dossier for each asset before the experts leave.
- Built on Botminds: agents, data, screens, and governance on one platform.
Transcribed from the film’s narration. Captions are on the player.